|
|||||
|
|
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer |
|
| Authors: | A Simon Pickard Maureen P Neary David Cella |
| Affiliation: | (1) Center for Pharmacoeconomic Research, Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, USA;(2) Global Health Outcomes, GlaxoSmithKline, Collegeville, Pennsylvania, USA;(3) Center for Outcomes Research and Education, Evanston Healthcare and Feinberg School of Medicine, Northwestern University, Chicago, USA |
| Abstract: | BackgroundUnderstanding what constitutes an important difference on a HRQL measure is critical to its interpretation. The aim of this study was to provide a range of estimates of minimally important differences (MIDs) in EQ-5D scores in cancer and to determine if estimates are comparable in lung cancer. |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |